HeartSciences Inc.
HSCS
$3.46
$0.113.28%
NASDAQ
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.77% | -1.52% | -11.13% | -12.31% | 5.98% |
| Total Depreciation and Amortization | -15.70% | 3.30% | -56.41% | 221.01% | 64.14% |
| Total Amortization of Deferred Charges | 66.67% | -- | -- | -100.00% | -75.03% |
| Total Other Non-Cash Items | 22.87% | -30.96% | -63.79% | -10.40% | -16.52% |
| Change in Net Operating Assets | 394.18% | -278.43% | -218.21% | 107.83% | -265.17% |
| Cash from Operations | 25.81% | -8.17% | -31.39% | 26.87% | -112.61% |
| Capital Expenditure | 100.00% | -- | -- | -454.55% | -27.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -481.48% | -237.50% | 98.68% | -50.50% | -924.49% |
| Cash from Investing | -170.69% | -625.00% | 99.27% | -122.76% | -2,360.00% |
| Total Debt Issued | -100.00% | -- | -- | -- | -100.00% |
| Total Debt Repaid | -2.15% | -33.78% | 29.59% | -46.83% | 49.40% |
| Issuance of Common Stock | 107.60% | -79.94% | 33.80% | -95.08% | 3,178.64% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -90.52% | 244.70% | 46.30% | -95.87% | 1,673.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -405.94% | 80.40% | -15.69% | -118.19% | 1,567.17% |